SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
SonALAsense has raised $46.0M in total funding. The most recent round was Grant. The last funding was announced in December 2024.
SonALAsense's investors include Advanced Research Projects Agency for Health, Keiretsu Forum, K4 Forum Mumbai Network.
SonALAsense is headquartered in Berkeley, United States.
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
SonALAsense is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SonALAsense — Funding & Investors." VCBacked, December 12, 2024, https://www.vcbacked.co/company/sonalasense. Accessed August 14, 2026.
VCBacked. (2024). SonALAsense — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sonalasense
{{cite web |title=SonALAsense — Funding & Investors |url=https://www.vcbacked.co/company/sonalasense |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated